论文部分内容阅读
BACKGROUND Non-alcoholic fatty liver disease(NAFLD)has a heterogeneous distribution across racial and ethnic groups,with a disproportionate burden among Hispanics.Although there are currently no approved therapies for treatment of NAFLD,several therapies